ArticlePharmacy practice

Tyrosine kinase inhibitors in patients with chronic myelogeneous leukemia: defining the role of social risk factors and non-adherence to treatment.

Lucas M Okumura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.